The health and family welfare department has planned to float fresh tender for procurement of medicine. The pharmaceutical companies that wish to participate in the bid will have to submit a certificate claiming that it fulfils good manufacturing practice (GMP) and good laboratory practice (GLP).
According to the Drug and Cosmetics Act, GMP and GLP is mandatory for pharmaceutical companies that wish to participate in the drug procurement bid floated by the health and family welfare department. Yet when the health and family welfare department floated the tender for the procurement of medicine on June 26 both GMP as well as GLP clause were not mentioned in the tender.
The health and family welfare department had planned to finalise the bid on July 20. Even as the process for finalising the companies to supply drug under rate contract had started, drug controller AL Arya shot off a letter to DG health Dr Vibha Lal stating that GMP and GLP clause had been ignored in the tender. Interestingly Arya is the member of the committee that finalised the drug purchase policy. A health department officer said, “Rather than embarrassing the health and family welfare department, Arya should have raised the issue in a meeting.”
Some medicine suppliers challenged the tender in Lucknow bench of the Allahabad High Court and submitted a copy of Arya’s letter stating that medicine procurement policy was flawed. The high court stayed the tender procedure.
Director, Central Medicine Supply Depot (CMSD) Dr SP Singh Lahota said, “fresh tender would be floated for procurement of drugs next week. The pharmaceutical companies will have to fulfill GMP and GLP qualification. The state government has decided to purchase 90% generic drug and 10% branded drug for supply to government hospitals. Rather than making centralised purchase, the medicine would be purchased by the CMOs in the districts.”